The role of matrix metalloproteinases -9 and -2 in development of neonatal chronic lung disease

Acta Paediatrica, International Journal of Paediatrics

Volumn 93, Issue 6, 2004, Pages 791-796

  Sweet, D G ^a,c   Curley, A E ^a   Chesshyre, E ^b   Pizzotti, J ^b   Wilbourn, M S ^b   Halliday, H L ^a   Warner, J A ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c ROYAL MATERNITY HOSPITAL   (United Kingdom)

Author keywords

Bronchoalveolar lavage; Chronic lung disease; Matrix metalloproteinases; Preterm baby; Tissue inhibitor of metalloproteinases

Indexed keywords

COLLAGEN TYPE 4; CORTICOSTEROID; GELATINASE A; GELATINASE B; PROTEIN INHIBITOR; PROTEINASE; PROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CHRONIC LUNG DISEASE; HUMAN; LIQUID; LUNG FIBROSIS; LUNG INJURY; LUNG LAVAGE; MAJOR CLINICAL STUDY; MEASUREMENT; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; PROTEIN FUNCTION;

BRONCHOALVEOLAR LAVAGE FLUID; CHRONIC DISEASE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 2942603153     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250410030027     Document Type: Article

References (28)

1. Ohnishi K, Takagi M, Kurokawa Y, Satomi S, Konttinen YT. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest 1998; 78: 1077-87
2. Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2 and increased parenchymal cell death in COPD. Chest 2000; 117: 684-94
3. Declaux C, Delacourt C, d'Ortho MP, Boyer V, Lafuma C, Harf A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996; 14: 288-95
4. Adamson IYR, Young L, Bowden DH. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol 1988; 130: 377-83
5. Uhal BD, Joshi I, Mundle S, Raza A, Pardo A, Selman M. Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. Am J Physiol 1995; 269: L819-28
6. Pardo A, Barrios R, Maldonado V, Melendez J, Perez J, Ruiz V, et al. Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia. Am J Pathol 1998; 153: 833-44
7. Cederqvist K, Sorsa T, Tervahartiala T, Maisi P, Reunanen K, Lassus P, et al. Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress. Pediatrics 2001; 108: 686-92
8. Curley AE, Sweet DG, Thornton CM, O'Hara MD, Chessyre E, Pizzotti J, et al. Chorioamnionitis and increased neonatal lung lavage fluid matrix metalloproteinase-9 levels - implications for antenatal origins of chronic lung disease. Am J Obstet Gynecol 2003; 188: 871-5
9. Danan C, Jarreau PH, Franco ML, Dassieu G, Grillon C, Abd Alsamad I, et al. Gelatinase activities in the airways of premature infants and development of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2002; 283: L1086-93
10. Kleiner DE, Stetler-Stevenson WG. Quantitive zymography: detection of pictogram quantities of gelatinases. Anal Biochem 1994; 218: 325-9
11. De Blic J, Midulla F, Barbato A, Clement A, Dab I, Eber E, et al. Bronchoalveolar lavage in children: European Respiratory Society Taskforce on Bronchoalveolar Lavage in Children. Eur Respir J 2000; 15: 217-31
12. Watterberg KL, Carmichael DF, Gerdes JS, Werner S, Backstrom C, Murphy S. Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasia. J Pediatr 1994; 125: 264-9
13. Michaelides MR, Curtin ML. Recent advances in matrix metalloproteinase inhibitors research. Curr Pharm Res 1999; 5: 787-819
14. Woessner JF, Jr.. MMPs and TIMPs - an historical perspective. Mol Biotechnol 2002; 22: 33-49
15. Skiles JW, Gonnella NC, Jeng AY. The design, structure and therapeutic application of matrix metalloproteinase inhibitors. Curr Med Chem 2001; 8: 425-74
16. Johnson LL, Dyer R, Hupe DJ. Matrix metalloproteinases. Curr Opin Chem Biol 1998; 2: 466-71
17. Ohki Y, Kato M, Kimura H, Nako Y, Tokuyama K, Morikawa A. Elevated type IV collagen in bronchoalveolar lavage fluid from infants with bronchopulmonary dysplasia. Biol Neonate 2001; 79: 34-8
18. Poston RN, Chanez P, Lacoste JY, Litchfield T, Lee TH, Bousquet J. Immunohistochemical characterisation of the cellular infiltration in asthmatic bronchi. Am Rev Respir Dis 1992; 145: 918-21
19. Yao PM, Buhler JM, d'Ortho MP, Lebargy F, Delclaux C, Harf A, et al. Expression of matrix metalloproteinase gelatinases A and B by cultured epithelial cells from human bronchial explants. J Biol Chem 1996; 271: 15580-9
20. Jobe AH, Ikegami M. Lung development and function in preterm infants in the surfactant treatment era. Ann Rev Physiol 2000; 62: 825-46
21. Schock BC, Sweet DG, Ennis M, Warner JA, Young IS, Halliday HL. Oxidative stress and increased type-IV collagenase levels in bronchoalveolar lavage fluid from newborn babies. Pediatr Res 2001; 50: 29-33
22. Sweet DG, Huggett MT, Moss TJ, Nitsos I, Warner JA, Halliday HL, et al. Increased lung collagenase levels in a sheep model of chorioamnionitis - implications for the development of chronic lung disease. Pediatr Res 2002; 51 Suppl 2: 474A (abstract 2765)
23. Shapiro SD, Campbell EJ, Kobayashi DK, Welgus HG. Dexamethasone selectively modulates basal and lipoploysaccharide induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. J Immunol 1991; 146: 2724-9
24. Mautino G, Henriquet C, Jaffuel D, Bousquet J, Capony F. Tissue inhibitor of metalloproteinase-1 levels in bronchoalveolar lavage fluid from asthmatic subjects. Am J Respir Crit Care Med 1999; 160: 324-30
25. Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthws JL, Barnes PJ. MMP-1, MMP-9 and the antiproteases secretory leukoprotease inhibitor (SLPI) and TIMP-1 were unaffected by inhaled steroid in COPD. Am J Respir Crit Care Med 1999; 160: 1635-9
26. Bosse M, Chakir J, Rouabhia M, Boulet LP, Audette M, Laviolette M. Serum MMP-9:TIMP-1 ratio correlates with steroid responsiveness in moderate to severe asthma. Am J Respir Crit Care Med 1999; 159: 596-602
27. Lacraz S, Nicod B, Galve-de-Rochemonteix, Baumberger J, Dayer JM, Welgus HG. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest 1992; 90: 382-8
28. Xu J, Kim GM, Ahmed SH, Yan P, Xu XM, Hsu CY. Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury. J Neurosci 2001; 21: 92-7